HSV 1/2 IgG, Herpeselect Type Specific Antibody
Test Summary
Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV type 2 is more commonly associated with genital tract and neonatal infections, while HSV type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients.
Aliases
- Herpes I &
- II Acute / Convalescent
- Herpes I &
- II, IgG Antibody
- Herpes I and II
- Herpes IgG 1 &
- 2
- Herpes Simplex
- Herpes Virus Titer 1 &
-  
- 2
- Herpes (comment: serum)
-  
Specimen Collection
Special Instructions
Preferred Specimen
Minimum Volume
Instructions
Patient Preparation
Storage
Transport Temperature
Specimen Stability
- Room Temperature = n/a
- Refrigerated = 7 days
- Frozen = at least 7 days
Limitations
Other Acceptable Specimens
Unacceptable Specimens
Order Code
EPIC (Premier) Code
Includes
CPT Code
- 86695
- 86696
Billing Code
- 500054
- 540055
CPT Statement
Methodology
FDA Status
Physician Attestation of Informed Consent
Testing Laboratory
2308 Sandridge Drive
Moraine OH, 45439
Department
Reference Range
Setup Schedule / Expected Turnaround Time
Specimen Collection
Special Instructions
Preferred Specimen
Minimum Volume
Instructions
Patient Preparation
Storage
Transport Temperature
Specimen Stability
- Room Temperature = n/a
- Refrigerated = 7 days
- Frozen = at least 7 days